BOTME研究:关于使用肉毒毒素用于中东人审美治疗的全国e-Delphi研究
Mohammed Al-Haddab1, Mohammed AlFada1, Yasser Alqubaisy2
1Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Journal of cosmetic dermatology
|October 13, 2025
概括
毒素A (BTX-A) 化品治疗对于皮肤有色的人来说越来越受欢迎. 这项研究提供了基于共识的建议,以标准化安全和有效的BTX-A注射实践.
科学领域:
- 化品皮肤学 化品皮肤学
- 审美医学是一种美学医学.
- 皮肤病学 皮肤病学
背景情况:
- 越来越多的人对肉毒素A (BTX-A) 化品治疗的需求.
- 越来越多的文化接受,社交媒体的影响和患者意识推动了BTX-A的使用.
- 缺乏标准化,基于证据的BTX-A在肤色人口中的指导.
研究的目的:
- 制定基于共识的临床建议,对皮肤有色患者进行美学性肉毒素注射.
- 在不同患者群体中建立BTX-A治疗的标准化实践.
- 为皮肤科医生治疗肤色皮肤提供基于证据的指导.
主要方法:
- 修改的e-Delphi方法涉及10名经过董事会认证的皮肤科医生,专门从事化品皮肤病学.
- 录取标准: ≥5年的经验和BTX-A使用的出版物/教学.
- 两个e-Delphi轮评估了29个基于证据的陈述;共识定义为≥70%的同意.
主要成果:
- 在29个关于BTX-A在肤色下使用的陈述中,共识达到了22个.
- 主要建议:在30-35岁时开始治疗,在脸部上部使用40-60 IU,16-20周间隔,2毫升盐溶液溶解,30度注射器.
- 商定了用于控制疼痛的局部EMLA;制定了治疗后活动限制等实际预防措施.
结论:
- 基于共识的建议旨在为肤色患者标准化BTX-A注射.
- 在不同人群中提高BTX-A治疗的安全性和有效性.
- 支持在美学皮肤病学中统一和可比的治疗结果.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
891
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
891
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Depolarizing Blockers: Pharmocokinetics
566
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
566


